SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 2.457
NA - Nord America 2.252
AS - Asia 1.457
SA - Sud America 298
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
OC - Oceania 1
Totale 6.497
Nazione #
US - Stati Uniti d'America 2.205
IE - Irlanda 716
SG - Singapore 437
DE - Germania 360
CN - Cina 356
SE - Svezia 350
HK - Hong Kong 308
RU - Federazione Russa 272
UA - Ucraina 270
BR - Brasile 232
IT - Italia 188
FI - Finlandia 174
VN - Vietnam 161
IN - India 52
GB - Regno Unito 43
KR - Corea 40
AR - Argentina 33
CA - Canada 26
ID - Indonesia 25
MX - Messico 17
EC - Ecuador 16
IR - Iran 16
BE - Belgio 14
FR - Francia 14
TR - Turchia 14
BD - Bangladesh 13
ES - Italia 12
PL - Polonia 12
ZA - Sudafrica 12
AT - Austria 8
NL - Olanda 8
PY - Paraguay 7
CZ - Repubblica Ceca 6
EU - Europa 6
JP - Giappone 6
BJ - Benin 5
CO - Colombia 4
IQ - Iraq 4
UZ - Uzbekistan 4
DO - Repubblica Dominicana 3
LT - Lituania 3
MY - Malesia 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
TN - Tunisia 3
VE - Venezuela 3
IL - Israele 2
KW - Kuwait 2
LB - Libano 2
PE - Perù 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BN - Brunei Darussalam 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
OM - Oman 1
Totale 6.497
Città #
Dublin 709
Jacksonville 483
Hong Kong 308
Dearborn 219
Beijing 194
Singapore 142
Wilmington 125
Chandler 106
Ashburn 93
Lawrence 88
Princeton 88
Ann Arbor 80
San Mateo 75
Moscow 70
Los Angeles 69
Ho Chi Minh City 61
Andover 58
Piemonte 53
Buffalo 43
Seoul 40
Düsseldorf 32
Dallas 30
New York 30
São Paulo 25
Hanoi 24
Boardman 17
Kunming 17
Hefei 15
Munich 15
Novara 15
Brussels 14
Monmouth Junction 14
Nanjing 13
Turin 13
Helsinki 12
Houston 12
Toronto 12
Santa Clara 11
Woodbridge 11
Frankfurt am Main 10
Warsaw 10
Kocaeli 9
Milan 9
Norwalk 9
Seattle 9
Atlanta 8
Bremen 8
Brooklyn 8
Denver 8
Dong Ket 8
Jakarta 8
Johannesburg 8
Nuremberg 8
Tianjin 8
Vienna 8
Boston 7
Chennai 7
Da Nang 7
Fairfield 7
Philadelphia 7
Redondo Beach 7
Stockholm 7
Ardabil 6
Council Bluffs 6
Fuzhou 6
Grafing 6
Guangzhou 6
Jinan 6
Leawood 6
Montreal 6
Nanchang 6
Quito 6
Shenyang 6
Tokyo 6
Vercelli 6
Zanjan 6
Cotonou 5
Curitiba 5
London 5
Manchester 5
Mexico City 5
Thái Bình 5
Trieste 5
Amsterdam 4
Biên Hòa 4
Brasília 4
Brno 4
Buenos Aires 4
Canoas 4
Chicago 4
Goiânia 4
Guayaquil 4
Haiphong 4
Hortolândia 4
Phoenix 4
Poplar 4
Querétaro 4
Rome 4
Ankara 3
Augusta 3
Totale 3.806
Nome #
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 147
InteractomeSeq: a web server for the identification and profiling of domains and epitopes from phage display and next generation sequencing data 126
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 124
RECOMBINANT ANTIBODIES AGAINST HUMAN TYPE II TRANSGLUTAMINASE AND USES THEREOF 117
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 111
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 109
A reliable screening procedure for coeliac disease in clinical practice 108
A definitive set of oligonucleotide primers for amplifying human V regions 103
An Air-well sparging minifermenter system for high-throughput protein production. 99
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 97
Antibodies in proteomics I: generating antibodies 97
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 96
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 95
The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs 95
A non-hypothesis-driven practical laboratory activity on functional metagenomics: “fishing” protein-coding DNA sequences from microbiomes 93
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ 92
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 92
Recombinant antibodies against CD55 and CD59 and uses thereof 91
Antibody library selection by the beta-lactamase protein fragment complementation assay 90
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids 88
Autoantibodies as predictors of disease 86
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors 82
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 81
Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome) 80
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 80
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 80
Dpp10 - A New Putative Regulatory ß-subunit Of Ito In Failing And Non-failing Human Heart 79
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. 78
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 78
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 78
A deep-blue OLED-based biochip for protein microarray fluorescence detection. 78
Anti transglutaminase antibodies cause ataxia in mice 77
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 77
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis 75
Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries 74
An albumin-derived peptide scaffold capable of binding and catalysis. 74
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 74
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of I (to) channel complex 72
Deglycosylation effects of tunicamycin and neuraminidase on Kv4.3 channel complex 72
Gliadin-dependent UPR induction directly triggers the expression of TG2 and pro-inflammatory cytokines, dysregulates intestinal permeability, and reduces CFTR expression in intestinal epithelial cells of celiac disease patients 70
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives 70
Anti-transglutaminase antibodies and age 70
Recombinant antibodies against CD55 and CD59 and uses thereof 70
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 67
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 67
Predicting antigenic peptides suitable for the selection of phage antibodies 67
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 66
Simple scale-up of recombinant antibody production using an UCOE containing vector 66
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 65
Treatment of arthritis models by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 65
The gut as site of production of autoimmune antibodies 65
Binders based on dimerised immunoglobulin VH domains 64
Anti-idiotypic response in mice expressing human autoantibodies 64
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 63
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 63
Phage display technology for human monoclonal antibodies 63
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. 63
The CXCR3/PLC/IP3-IP3R axis is responsible for the ignition of UPR in intestinal epithelial cells exposed to gliadin peptide, during the onset of celiac disease 63
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 62
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease 61
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito 61
Role of the C-terminal fragment of osteopontin in multiple sclerosis 61
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 60
Primer sets for cloning the human repertoire of T cell Receptor Variable regions 60
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 59
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display 57
Profiling celiac disease antibody repertoire. 57
Exploiting recombination in single bacteria to make large phage antibody libraries 56
Method for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof 56
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 56
Plasmid incompatibility: more compatible than previously thought? 56
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease 55
Rapid interactome profiling by massive sequencing 55
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. 54
Selecting open reading frames from DNA 52
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine 52
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease 51
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice 49
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 49
Mass screening for coeliac disease using antihuman transglutaminase antibody assay 49
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. 48
Mucosal tissue transglutaminase expression in celiac disease 47
Dual sugar gut-permeability testing on blood drop in animal models 46
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 46
Development of a novel rapid non-invasive screening test for coeliac disease 45
Using archaeal histones for precise DNA fragmentation 45
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. 42
Gluten ataxia: passive transfer in a mouse model 41
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 40
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet 39
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 39
Selection and characterization of a novel agonistic human recombinant anti-TRAIL_R2 minibody with anti_leukemic activity 39
Totale 6.541
Categoria #
all - tutte 36.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 16 91 14 93 19 97 19
2021/2022625 38 16 108 79 33 2 65 17 44 40 66 117
2022/20231.227 94 44 68 28 43 111 22 66 699 3 31 18
2023/2024298 29 14 22 8 61 5 72 5 0 1 24 57
2024/2025867 10 3 28 6 18 47 117 47 262 135 33 161
2025/20261.569 125 190 400 545 271 38 0 0 0 0 0 0
Totale 6.541